Derivatives of butyric acid as potential anti‐neoplastic agents

International Journal of Cancer

Volumn 49, Issue 1, 1991, Pages 66-72

  Rephaeli, Ada ^a   Rabizadeh, Ester ^a   Aviram, Adina ^a   Shaklai, Mati ^a   Ruse, Margaretta ^b   Nudelman, Abraham ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; BUTYRIC ACID ISOBUTYRYLOXYMETHYL ESTER; CYCLOPHOSPHAMIDE; PIVALOYLOXYMETHYL BUTYRATE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG TOXICITY; GROWTH INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTINEOPLASTIC AGENTS; BUTYRATES; BUTYRIC ACID; BUTYRIC ACIDS; CELL DIFFERENTIATION; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; LUNG NEOPLASMS; MICE; PRODRUGS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0025862375     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910490113     Document Type: Article

References (25)

1. Induced cell differentiation in cancer therapy
2. Status of the NCI preclinical antitumor drug discovery screen
3. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds
4. Acyloxymethyl ester of ampicillin
5. Effects of differing concentrations of sodium butyrate on rat intestinal neoplasia
6. Primary bioassay of human tumor stem cells
7. Butyric acid: inhibition of non‐leukemic and chronic myeloid leukemia, granulocyte macrophage clonal growth
8. Diet, butyric acid and differentiation of gastrointestinal tract tumors
9. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications
10. The c‐fos proto‐oncogene in murine 3LL carcinoma clones controls the expression of MHC genes
11. Butyric acid a potent inducer of erythroid differentiation in cultured erythroleukemia cells
12. Clinical pharmacology of sodium butyrate in patients with acute leukemia
13. Effect of polar organic compounds on leukemic cells
14. 5‐fluorouracil derivatives. IV. Synthesis and anti‐tumoractive acyloxyalkyl‐5‐fluorouracils
15. Butyric acid: a small fatty acid with diverse biological functions
16. Induction of tumor‐cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms
17. Anti‐neoplastic activity of a butyric acid pro‐drug. 15th International Cancer Congress, Hamburg, Germany
18. Effect of the cell‐differentiation inducers, butyrate, retinoic acid and low‐dose cytosine arabinoside on leukemic cells of patients with acute non‐lymphatic leukemia. Comparison of in vitro and in vivo
19. Cell differentiation and bypassing of genetic defects in the suppression of malignancy
20. New approaches to anti‐tumor drug screening: the human tumor colony‐forming assay
21. Molecular analysis of sodium‐butyrate‐induced growth arrest
22. Buty‐rate suppression of histone de‐acetylation leads to accumulation of poly‐acetylated forms of histones H3 and H4 and increased DNase‐I sensitivity of the associated DNA sequences
23. Orally active esters of cephalosporin antibiotics. Synthesis and biological properties of acyloxy esters of 7‐(D‐2‐amino‐2‐phenylacetam)‐3‐[5‐methyl‐(1,3,4‐thiadiazol‐2‐ylthiomethyl]‐3‐cephem‐4‐carboxylic acid